Combining Endocrine Therapy with Trastuzumab Emtansine Improves Progression-Free Survival and Overall Survival in HER2-Positive, Hormone Receptor-Positive Metastatic Breast Cancer
Kınıkoğlu, Oğuzcan, Odabas, Hatice, Altıntaş, Yunus Emre, Yıldız, Anıl, Çakan, Burçin, Akdağ, Goncagül, Yıldırım, Sedat, Bal, Hamit, Kaya, Tuğba, Tünbekici, Salih, Işık, Deniz, Başoğlu, Tuğba, Yıldırım, Mahmut Emre, Turan, Nedim
Published in Medicina (Kaunas, Lithuania) (01.06.2024)
Published in Medicina (Kaunas, Lithuania) (01.06.2024)
Get full text
Journal Article
The role of laboratory indices on treatment response and survival in breast cancer receiving neoadjuvant chemotherapy
Yildirim, Sedat, Dogan, Akif, Akdag, Goncagul, Yüksel Yasar, Zeynep, Bal, Hamit, Kinikoglu, Oguzcan, Oksuz, Sila, Ozkerim, Ugur, Tunbekici, Salih, Yildiz, Hacer Sahika, Alan, Ozkan, Coban Kokten, Sermin, Isik, Deniz, Surmeli, Heves, Basoglu, Tugba, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim
Published in Scientific reports (27.05.2024)
Published in Scientific reports (27.05.2024)
Get full text
Journal Article
Neoadjuvant Chemotherapy and Pathologic Complete Response in HR+/HER2- Breast Cancer: Impact of Tumor Ki67 and ER Status
Akdag, Goncagul, Yildirim, Sedat, Dogan, Akif, Yuksel Yasar, Zeynep, Bal, Hamit, Kinikoglu, Oguzcan, Oksuz, Sila, Ozkerim, Ugur, Tunbekici, Salih, Yildiz, Hacer Sahika, Turkoglu, Ezgi, Alan, Ozkan, Coban Kokten, Sermin, Isik, Deniz, Sever, Ozlem Nuray, Odabas, Hatice, Yildirim, Mahmut Emre, Turan, Nedim
Published in Chemotherapy (Basel) (16.02.2024)
Published in Chemotherapy (Basel) (16.02.2024)
Get more information
Journal Article